Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)

BACKGROUND: The enhanced knowledge of cancer biology has led to considerable advancement in systemic therapy for advanced breast cancer. Recently, studies showed that cyclin-dependent kinase (CDK) 4/6 inhibitor, when added to endocrine therapy, had improved the outcomes of patients with advanced ER-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alomran, Reem, White, Michelle, Bruce, Melissa, Bressel, Mathias, Roache, Susan, Karroum, Lama, Hanna, Gerard G., Siva, Shankar, Goel, Shom, David, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989018/
https://www.ncbi.nlm.nih.gov/pubmed/33757458
http://dx.doi.org/10.1186/s12885-021-08042-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989018/
https://www.ncbi.nlm.nih.gov/pubmed/33757458
http://dx.doi.org/10.1186/s12885-021-08042-w

Ejemplares similares